• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤休眠与癌基因成瘾

Tumor dormancy and oncogene addiction.

作者信息

Felsher Dean W

机构信息

Division of Oncology, Department of Medicine, Stanford University, Palo Alto, CA, USA.

出版信息

APMIS. 2008 Jul-Aug;116(7-8):629-37. doi: 10.1111/j.1600-0463.2008.01037.x.

DOI:10.1111/j.1600-0463.2008.01037.x
PMID:18834407
Abstract

Cancer is caused by genetic changes that activate oncogenes or inactivate tumor suppressor genes. The repair or inactivation of mutant genes may be effective in the treatment of cancer. Indeed, drugs that target oncogenes can be effective in the treatment of cancer. However, it is still unclear why the inactivation of a single cancer-associated gene would ever result in the elimination of tumor cells. In experimental transgenic mouse models the consequences of oncogene inactivation depend upon the genetic and cellular context. In some cases, oncogene inactivation results in the elimination of all or almost all tumor cells through apoptosis by the phenomenon described as oncogene addiction. In other cases, oncogene inactivation predominantly results in the terminal differentiation or cellular senescence of tumor cells. In yet others, oncogene inactivation results in the apparent loss of the neoplastic properties of tumor cells, which now appear and behave like normal cells; however, upon oncogene reactivation at least some of these cells rapidly recover their neoplastic phenotype. Thus, oncogene inactivation can result in a state of tumor dormancy. Hence, understanding when and how oncogene inactivation induces apoptosis, differentiation, and senescence within a tumor will be important when developing effective strategies for the treatment of cancer.

摘要

癌症是由激活癌基因或使肿瘤抑制基因失活的基因变化引起的。突变基因的修复或失活可能对癌症治疗有效。事实上,靶向癌基因的药物可有效治疗癌症。然而,尚不清楚为何单个癌症相关基因的失活会导致肿瘤细胞的消除。在实验性转基因小鼠模型中,癌基因失活的后果取决于基因和细胞背景。在某些情况下,癌基因失活会通过被称为癌基因成瘾的现象,导致所有或几乎所有肿瘤细胞通过凋亡而被消除。在其他情况下,癌基因失活主要导致肿瘤细胞的终末分化或细胞衰老。在另外一些情况下,癌基因失活会导致肿瘤细胞的肿瘤特性明显丧失,这些细胞现在看起来和行为都像正常细胞;然而,在癌基因重新激活后,至少其中一些细胞会迅速恢复其肿瘤表型。因此,癌基因失活可导致肿瘤休眠状态。因此,在制定有效的癌症治疗策略时,了解癌基因失活何时以及如何在肿瘤内诱导凋亡、分化和衰老将非常重要。

相似文献

1
Tumor dormancy and oncogene addiction.肿瘤休眠与癌基因成瘾
APMIS. 2008 Jul-Aug;116(7-8):629-37. doi: 10.1111/j.1600-0463.2008.01037.x.
2
Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?癌基因成瘾与癌基因遗忘:或许不仅仅是一种不良习惯?
Cancer Res. 2008 May 1;68(9):3081-6; discussion 3086. doi: 10.1158/0008-5472.CAN-07-5832.
3
Tumor dormancy and MYC inactivation: pushing cancer to the brink of normalcy.肿瘤休眠与MYC失活:将癌症推向正常边缘
Cancer Res. 2005 Jun 1;65(11):4471-4. doi: 10.1158/0008-5472.CAN-05-1172.
4
Tumor dormancy: death and resurrection of cancer as seen through transgenic mouse models.肿瘤休眠:通过转基因小鼠模型看癌症的死亡与复苏
Cell Cycle. 2006 Aug;5(16):1808-11. doi: 10.4161/cc.5.16.3111. Epub 2006 Aug 15.
5
Rehabilitation of cancer through oncogene inactivation.通过癌基因失活实现癌症康复。
Trends Mol Med. 2005 Jul;11(7):316-21. doi: 10.1016/j.molmed.2005.05.003.
6
Is oncogene addiction angiogenesis-dependent?癌基因成瘾是否依赖血管生成?
Cold Spring Harb Symp Quant Biol. 2005;70:389-97. doi: 10.1101/sqb.2005.70.042.
7
[Better understanding of the biology of cancer cells].[对癌细胞生物学的更深入理解]
Ugeskr Laeger. 2000 Sep 25;162(39):5199-204.
8
Reversibility of oncogene-induced cancer.癌基因诱导癌症的可逆性。
Curr Opin Genet Dev. 2004 Feb;14(1):37-42. doi: 10.1016/j.gde.2003.12.008.
9
Reversing cancer from inside and out: oncogene addiction, cellular senescence, and the angiogenic switch.从内而外逆转癌症:癌基因成瘾、细胞衰老与血管生成开关
Lymphat Res Biol. 2008;6(3-4):149-54. doi: 10.1089/lrb.2008.63403.
10
Sustained loss of a neoplastic phenotype by brief inactivation of MYC.通过短暂失活MYC实现肿瘤表型的持续丧失。
Science. 2002 Jul 5;297(5578):102-4. doi: 10.1126/science.1071489.

引用本文的文献

1
Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?靶向分子疗法治疗食管腺癌,我们做到了吗?
Cancers (Basel). 2020 Oct 22;12(11):3077. doi: 10.3390/cancers12113077.
2
Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.动物癌症模型中关于永生性和自主性的证据常常未被提供,这在癌症生物学的关键问题上造成了混乱。
J Cancer. 2020 Mar 4;11(10):2887-2920. doi: 10.7150/jca.41324. eCollection 2020.
3
Not gene therapy, but genetic surgery-the right strategy to attack cancer.
不是基因疗法,而是基因手术——攻克癌症的正确策略。
Mol Gen Microbiol Virol. 2009;24(3):93-113. doi: 10.3103/S089141680903001X. Epub 2009 Oct 8.
4
While it is not deliberate, much of today's biomedical research contains logical and technical flaws, showing a need for corrective action.虽然并非有意为之,但当今许多生物医学研究都存在逻辑和技术缺陷,需要采取纠正措施。
Int J Med Sci. 2018 Jan 19;15(4):309-322. doi: 10.7150/ijms.23215. eCollection 2018.
5
Retinoic Acid affects Lung Adenocarcinoma growth by inducing differentiation via GATA6 activation and EGFR and Wnt inhibition.维甲酸通过激活 GATA6 并抑制 EGFR 和 Wnt 来诱导分化,从而影响肺腺癌的生长。
Sci Rep. 2017 Jul 6;7(1):4770. doi: 10.1038/s41598-017-05047-z.
6
In Vitro Screening for Cytotoxic Activity of Herbal Extracts.草药提取物细胞毒活性的体外筛选
Evid Based Complement Alternat Med. 2017;2017:2675631. doi: 10.1155/2017/2675631. Epub 2017 Mar 13.
7
Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.Apc基因恢复促进细胞分化并重建结直肠癌中的隐窝内环境稳定。
Cell. 2015 Jun 18;161(7):1539-1552. doi: 10.1016/j.cell.2015.05.033.
8
p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia.在急性白血病小鼠模型中,p19ARF是细胞衰老以及与MYC失活相关的先天免疫反应的关键介质。
Oncotarget. 2015 Feb 28;6(6):3563-77. doi: 10.18632/oncotarget.2969.
9
BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin.BRCA1-IRIS 失活使卵巢肿瘤对顺铂敏感。
Oncogene. 2015 Jun 4;34(23):3036-52. doi: 10.1038/onc.2014.237. Epub 2014 Aug 18.
10
TBK1 regulates prostate cancer dormancy through mTOR inhibition.TBK1 通过抑制 mTOR 调节前列腺癌休眠。
Neoplasia. 2013 Sep;15(9):1064-74. doi: 10.1593/neo.13402.